Projection of long-term outcomes using X-rays and pooled cytology in lung cancer screening
Dongfeng Wu1, Diane Erwin2, Seongho Kim1
1Department of Bioinformatics and Biostatistics, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, 2Information Management Services, Inc, Rockville, MD, USA
Purpose: To investigate the long-term outcome of using X-ray and the 3-day "pooled" sputum cytology in lung cancer screening using the Mayo Lung Project data.
Methods: In this study, the statistical method developed by the authors using the Mayo Lung Project data was applied. Each participant eventually falls into one of the four categories depending on whether they would be diagnosed with lung cancer and whether symptoms would have appeared before death. The derived probability of each outcome was presented. Bayesian inference was made for the percentages of true-early-detection, no-early-detection, over-diagnosis, and symptom-free-life. The authors present estimates of these proportions for male heavy smokers by using Markov Chain Monte Carlo samples in the simulation. Human lifetime was treated as a random variable.
Results: The probability that a male heavy smoker will live a lung cancer-free life is about 80%; the probability for developing lung cancer for a male heavy smoker is about 20%, much higher than in the general population (6.95%). The probability of over-diagnosis is low, about 6%–9% among the early detected cases. The probability of true-early-detection is greater than 90%. Finally, the probability of no-early-detection increases as the screening interval increases; among the diagnosed cases, it is about 15% if the screens are 6 months apart, and it is close to 50% if the screens are 2 years apart.
Conclusion: This research provides a framework and a systematic approach for policy makers regarding how to evaluate long-term outcomes of chest X-ray and pooled sputum cytology in lung cancer screening.
Keywords: true early detection, no early detection, over diagnosis, symptom-free life, pooled sputum cytology
This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
Other article by this author:
Published Date: 27 April 2011
Readers of this article also read:
Hamon A, Tosolini M, Ycart B, Pont F, Fournie JJ
Published Date: 28 November 2014
Group classification based on high-dimensional data: application to differential scanning calorimetry plasma thermogram analysis of cervical cancer and control samples
Rai SN, Pan J, Cambon A, Chaires JB, Garbett NC
Published Date: 17 April 2013
Comparing the performance of different multiple imputation strategies for missing binary outcomes in cluster randomized trials: a simulation study
Ma J, Raina P, Beyene J, Thabane L
Published Date: 20 December 2012
Tabatabai MA, Eby WM, Li H, Bae S, Singh KP
Published Date: 29 November 2012
Yamamoto K, Tomizawa S
Published Date: 19 November 2012
Guo Q, Hall G, McKinnon M, Thabane L, Goeree R, Pullenayegum E
Published Date: 21 May 2012
Statistical analysis of repeated microRNA high-throughput data with application to human heart failure: a review of methodology
Rai SN, Ray HE, Yuan X, Pan J, Hamid T, Prabhu SD
Published Date: 13 April 2012
Fu WJ, Wu T, Wang Y, Meng H, Huang J
Published Date: 23 September 2011
Published Date: 5 September 2011
Published Date: 2 August 2011